MSN: New migraine prevention guidance highlights CGRP drugs, broad eligibility (AUG 31, 2026)
Larner Associate Professor of Neurological Sciences Rebecca Burch, M.D., helped write updated guidelines from the American Academy of Neurology and the American Headache Society aimed at helping clinicians identify which migraine prevention drugs may be most effective for certain patients. Based on evidence from a systematic review of migraine prevention drugs, the new guidelines were published in Neurology.
Additional media coverage: American Academy of Neurology, Carroll (Iowa) Times Herald, Epoch Health, Healio, Juta Medical Brief, LakeExpo, MedicalXpress, MedPageToday, MedScape, NeurologyLive, ScienceAlert, ScienceNews, STAT, Watertown (Wis.) Daily Times, Yahoo
Read Larner News story about updated migraine prevention guidelines